About: Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.12 (-1.27%)
IVA NASDAQ Inventiva Sa
Inventiva Sa share price
IVA price activity
Last Price
$2.930
Change (24hr)
-0.20 USD (-6.25%)
Volume
799.37K
Volume (4w avg)
-
Open
$3.02
Day Range
$2.93 - $3.02
Previous Close
$3.12
Last Trade
13 Oct, 5:33 pm GMT+0
Delayed
13 Oct, 5:33 pm GMT+0
IVA price performance
Delayed
13 Oct, 5:33 pm GMT+0
IVA Market Signals